Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro
Abdulhameed Al‐Ghabkari, Aru Narendran
Cancer Biology & Therapy (2021) Vol. 22, Iss. 4, pp. 333-344
Open Access | Times Cited: 10

Showing 10 citing articles:

The regulatory effect and molecular mechanism of Epstein-Barr virus protein LMP-1 in SLE susceptibility gene expression
Xiang Zhang, Shouci Hu, P. Luo, et al.
Immunology Letters (2025), pp. 106993-106993
Closed Access
Role of epigenetics in paediatric cancer pathogenesis & drug resistance
Jia Yu Leung, Hsin Yao Chiu, Reshma Taneja
British Journal of Cancer (2025)
Closed Access
The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase
Eva Monte-Serrano, Patricia Morejón‐García, Ignacio Campillo‐Marcos, et al.
Epigenetics & Chromatin (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
Pedro A. Lazo
Cancers (2022) Vol. 14, Iss. 16, pp. 4050-4050
Open Access | Times Cited: 10
Tumor-suppressive functions of protein lysine methyltransferases
Nur Aziz, Yo Han Hong, Han Gyung Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 12, pp. 2475-2497
Open Access | Times Cited: 5
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8
Emerging role of EZH2 in rheumatic diseases: A comprehensive review
Wang‐Dong Xu, Qi Huang, An‐Fang Huang
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 11, pp. 1230-1238
Closed Access | Times Cited: 7
The Regulatory Effect and Molecular Mechanism of Epstein-Barr Virus Protein Lmp-1 in Sle Susceptibility Gene Expression
Xiang Zhang, Shouci Hu, Zhiyu Li, et al.
(2024)
Closed Access
Pharmacological Advancements of PRC2 in Cancer Therapy: A Narrative Review
Michael S. Wang, Jonathan Sussman, Jun-Jun Xu, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1645-1645
Open Access
Progress Toward Epigenetic Targeted Therapies for Childhood Cancer
Athanasia Liapodimitri, Ashley R Tetens, Jordyn Craig-Schwartz, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4149-4149
Open Access
Development of a UPLC–MS/MS method for determination of a dual EZH1/2 inhibitor UNC1999 in rat plasma
Chunling Zhou, Aiping He, Qiang Kang, et al.
Bioanalysis (2021) Vol. 14, Iss. 2, pp. 67-74
Closed Access | Times Cited: 1
Page 1

Scroll to top